Amesite Inc. announced on May 18, 2026 that it secured a new home care enterprise customer — its largest to date — for its NurseMagic AI documentation platform. The news sent AMST stock up 190% in premarket trading Tuesday.
The customer serves approximately 2,700 patients and will roll out NurseMagic across its full workforce. The platform will tie into both electronic medical record and electronic visit verification systems.
The core promise of the deployment is time savings. Documentation can currently eat up to 16 hours per caregiver per week, and NurseMagic is designed to cut that burden substantially.
CEO and Founder Dr. Ann Marie Sastry framed it plainly: “This 2,700-census deployment validates the strength of our architecture.” She added that the company can launch new customers quickly without the consulting fees and custom development costs typical of legacy providers.
The deployment supports multiple user roles, layered permissions, and custom documentation across thousands of patients — without a lengthy onboarding process Amesite says can take weeks or months with older systems.
The win comes as Amesite has been tightening its cost structure. Principal Finance and Accounting Officer Sarah Berman noted an approximately 18% reduction in operating spend over the last six quarters, even as the company grew its paying customer base.
That kind of efficiency alongside expansion doesn’t go unnoticed for a micro-cap stock. Amesite currently carries a market cap of around $4.48 million, which puts any meaningful enterprise win in sharp financial relief.
Director of Corporate Operations Madison Bush reported that sales and marketing efforts are generating roughly 4,200 web visits per day. She also noted that over 70% of prospective customers in active discussions have self-scheduled demos through the website.
Beyond the current deployment, Amesite says it is in discussions with additional organizations representing several thousand more patients in aggregate. The company did not name these prospects or give a timeline.
NurseMagic operates across more than 100 professions in 50 states and 21 countries. The platform supports multilingual capabilities and complies with HIPAA regulations.
The stock has an average daily trading volume of around 682,000. Technical sentiment for the stock is currently rated as a sell, though that rating was issued before Tuesday’s announcement.
The 2,700-patient deployment is the company’s largest and, according to management, marks NurseMagic’s transition from an assistive tool to what they describe as core clinical infrastructure in the non-acute care market.
The post Amesite (AMST) Stock Rockets 190% — Here’s Why One Deal Changed Everything appeared first on CoinCentral.
